+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of antifungal treatment on the prevalence of yeasts in HIV-infected subjects

Effect of antifungal treatment on the prevalence of yeasts in HIV-infected subjects

Journal of Medical Microbiology 55(Pt 9): 1279-1284

Oral candidiasis, the most common opportunistic infection in patients with HIV infection, is usually associated with Candida albicans. Several factors may influence the carriage of Candida, including immunocompromised conditions and HIV infection, colonization by yeasts from different geographical areas and antimycotic treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 011991935

Download citation: RISBibTeXText

PMID: 16914661

DOI: 10.1099/jmm.0.46588-0

Related references

Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3. Antimicrobial Agents and ChemoTherapy 46(5): 1455-1461, 2002

Prevalence and antifungal susceptibility of yeasts obtained from the oral cavity of elderly individuals. Mycopathologia 162(1): 39-44, 2006

Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women. Indian Journal of Pathology & Microbiology 44(3): 313-314, 2002

Prevalence of yeasts in the vagina of cow and sheep, experimental pathogenicity for mice, and sensitivity to different antifungal agents. Anales de la Facultad de Veterinaria de Leon 1978; 22(2): 375-428, 1976

Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents. Revista Argentina de Microbiologia 38(1): 9-12, 2006

Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. European Journal of Epidemiology 13(4): 447-450, 1997

High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore. Bmc Infectious Diseases 13: 90-90, 2013

Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrobial Agents and ChemoTherapy 41(3): 617-623, 1997

The antifungal effect upon asporogenous yeasts of trichomycin. Nuovi Ann. Ig, 9: 6, 557-559, 1958

Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients. Aids Patient Care and Stds 22(8): 613-618, 2008

Nitroxoline and usual antifungal agents comparison of the antifungal activity of 238 strains of yeasts. Bulletin de la Societe Francaise de Mycologie Medicale 15(1): 265-268, 1986

Collaborative evaluation of Etest for antifungal susceptibility testing with five antifungal agents against pathogenic yeasts. Abstracts of the General Meeting of the American Society for Microbiology 94(0): 608, 1994